Clinical Trial Update: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update describing testing of PDS0101, an anti-HPV therapy, in people living with HIV. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer
• Human Immunodeficiency Virus Infection
• Human Papillomavirus Infection

Drugs mentioned

• PDS0101

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: HPV Associated Cancers, HIV (Human Immunodeficiency Virus) | Phase 2 | Status: NOT_YET_RECRUITING